Dissociable Effects of Selective 5-HT2A and 5-HT2C Receptor Antagonists on Serial Spatial Reversal Learning in Rats
The DOI matches its Crossref record; 110 of the 112 references it cites were found in a registry or an index.
Abstract
Serotonin (5-hydroxytryptamine, or 5-HT) is strongly implicated in the ability to shift behavior in response to changing stimulus-reward contingencies. However, there is little information on the contribution of different 5-HT receptors in reversal learning. Thus, we investigated the effects of systemic administration of the 5-HT(2A) antagonist M100907 (0, 0.01, 0.03, and 0.1 mg/kg, i.p.) and the 5-HT(2C) antagonist SB 242084 (0, 0.1, 0.3, and 1.0 mg/kg, i.p.) on the performance of an instrumental two-lever spatial discrimination and serial spatial reversal learning task, where both levers were presented and only one was reinforced. The rat was required to respond on the reinforced lever under a fixed ratio 3 schedule of reinforcement. Following attainment of criterion, a series of within-session reversals was presented. Neither M100907 nor SB 242084 altered performance during spatial discrimination and retention of the previously reinforced contingencies. M100907 significantly impaired reversal learning by increasing both trials to criterion (only at the highest dose) and incorrect responses to criterion in Reversal 1, a pattern of behavior manifested as increased perseverative responding on the previously reinforced lever. In contrast, SB 242084 improved reversal learning by decreasing trials and incorrect responses to criterion in Reversal 1, with significantly fewer perseverative responses. These data support the view that 5-HT(2A) and 5-HT(2C) receptors have distinct roles in cognitive flexibility and response inhibition. The improved performance in reversal learning observed following 5-HT(2C) receptor antagonism suggests these receptors may offer the potential for therapeutic advances in a number of neuropsychiatric disorders where cognitive deficits are a feature, including obsessive-compulsive disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study in rats suggests that serotonin stimulation of 5-HT2C receptors impairs reward reversal162, a function that is highly dependent on the orbital PFC.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [162]
In the citing paper
“the 5-HT2C receptor antagonist SB 242084 improved reversal learning in naïve rats (Alsio et al 2015, Boulougouris et al 2008, Boulougouris & Robbins 2010)”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Boulougouris et al 2008
In the citing paper
“the 5-HT2A receptor antagonist MDL 100-907, administered systemically or intra-OFC, produced deficits in reversal learning in naïve rats (Boulougouris et al 2008, Furr et al 2012)”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Boulougouris et al 2008
Citations
Cites
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785 · cited 2×
“Given that addiction and compulsivity seem to share underlying neural substrates such as the OFC and the DA system (Stein et al, 1995; Jentsch and Taylor, 1999; Everitt and Robbins, 2005; Kalivas and Volkow, 2005), the present finding that SB 242084 reduced perseverative responding suggests that 5-HT2C receptors of di…”
BackgroundSelf-citationA review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161 · cited 2×
“0 (Barnes and Sharp, 1999).”
BackgroundInfluentialThe Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757 · cited 2×
“…to share underlying neural substrates such as the OFC and the DA system (Stein et al, 1995; Jentsch and Taylor, 1999; Everitt and Robbins, 2005; Kalivas and Volkow, 2005), the present finding that SB 242084 reduced perseverative responding suggests that 5-HT2C receptors of distinct brain areas…”
BackgroundJentsch, J. D., & Taylor, J. R. (1999) · Psychopharmacology · doi:10.1007/pl00005483 · Cited by 1,545 · cited 2×
“Given that addiction and compulsivity seem to share underlying neural substrates such as the OFC and the DA system (Stein et al, 1995; Jentsch and Taylor, 1999; Everitt and Robbins, 2005; Kalivas and Volkow, 2005), the present finding that SB 242084 reduced perseverative responding suggests that…”
BackgroundDissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527 · cited 4×
“…implicated the orbitofrontal cortex (OFC) (human, Rolls et al, 1994; nonhuman primate, Settlage et al, 1948; Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; rat, Chudasama and Robbins, 2003; McAlonan and Brown, 2003; Boulougouris et al, 2007) and the ventrolateral sector of caudate…”
BackgroundMethodInfluentialSelf-citationMedial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat
Birrell, J. M., & Brown, V. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04320.2000 · Cited by 1,421 · cited 2×
“The reversal learning task has been used as a measure of behavioral flexibility in humans (Rolls et al, 1994; Rogers et al, 2000; Murphy et al, 2002; Fellows and Farah, 2003), nonhuman primates (Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; Clarke et al, 2004, 2005, 2007; Lee et al, 2007), and rats (Birrell…”
MethodRolls, E. T., Hornak, J., Wade, D., & McGrath, J. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.12.1518 · Cited by 1,005 · cited 2×
“The reversal learning task has been used as a measure of behavioral flexibility in humans (Rolls et al, 1994; Rogers et al, 2000; Murphy et al, 2002; Fellows and Farah, 2003), nonhuman primates (Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; Clarke et al, 2004, 2005, 2007; Lee et al,…”
BackgroundMethodAbramowitz, J. S., Taylor, S., & McKay, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60240-3 · Cited by 1,002
Pompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 881 · cited 6×
“Eberle-Wang et al (1997) demonstrated the presence of 5-HT2C mRNA within inhibitory GABAergic interneurons making direct synaptic contact with dopaminergic cell bodies in both the VTA and substantia nigra.”
BackgroundInfluentialLimbic lesions and the problem of stimulus—Reinforcement associations
Jones, B., & Mishkin, M. (1972) · Experimental Neurology · doi:10.1016/0014-4886(72)90030-1 · Cited by 868 · cited 13×
“…measure of behavioral flexibility in humans (Rolls et al, 1994; Rogers et al, 2000; Murphy et al, 2002; Fellows and Farah, 2003), nonhuman primates (Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; Clarke et al, 2004, 2005, 2007; Lee et al, 2007), and rats (Birrell and Brown, 2000;…”
BackgroundMethodInfluentialCognitive Inflexibility After Prefrontal Serotonin Depletion
Clarke, H. F., Dalley, J. W., Crofts, H. S., Robbins, T. W., & Roberts, A. C. (2004) · Science · doi:10.1126/science.1094987 · Cited by 632 · cited 3×
“…1994; Rogers et al, 2000; Murphy et al, 2002; Fellows and Farah, 2003), nonhuman primates (Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; Clarke et al, 2004, 2005, 2007; Lee et al, 2007), and rats (Birrell and Brown, 2000; McAlonan and Brown, 2003; Idris et al, 2005; van der Meulen et…”
BackgroundSelf-citationFellows, L. K. (2003) · Brain · doi:10.1093/brain/awg180 · Cited by 631 · cited 2×
“The reversal learning task has been used as a measure of behavioral flexibility in humans (Rolls et al, 1994; Rogers et al, 2000; Murphy et al, 2002; Fellows and Farah, 2003), nonhuman primates (Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; Clarke et al, 2004, 2005, 2007; Lee et al, 2007), and rats (Birrell…”
MethodOrbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat
McAlonan, K., & Brown, V. J. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.019 · Cited by 618 · cited 12×
“It is noteworthy that OFC lesions (marmoset, Dias et al, 1996; rat, Boulougouris et al, 2007) also impaired the first reversal only.”
BackgroundMethodInfluentialBehavioral effects of selective ablation of the caudate nucleus.
Divac, I., Rosvold, H. E., & Szwarcbart, M. K. (1967) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0024348 · Cited by 562 · cited 1×
“…1996; rat, Chudasama and Robbins, 2003; McAlonan and Brown, 2003; Boulougouris et al, 2007) and the ventrolateral sector of caudate nucleus (monkey, Divac et al, 1967; rat, Dunnett and Iversen, 1980), while a recent study demonstrated that basolateral amygdala lesions abolished OFC-induced…”
Chudasama, Y., & Robbins, T. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08771.2003 · Cited by 543 · cited 1×
“…cortex (OFC) (human, Rolls et al, 1994; nonhuman primate, Settlage et al, 1948; Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; rat, Chudasama and Robbins, 2003; McAlonan and Brown, 2003; Boulougouris et al, 2007) and the ventrolateral sector of caudate nucleus (monkey, Divac et…”
BackgroundSelf-citationSB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist
KENNETT, G. A., WOOD, M. D., BRIGHT, F., TRAIL, B., RILEY, G., HOLLAND, V., AVENELL, K. Y., STEAN, T., UPTON, N., BROMIDGE, S., et al. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00038-5 · Cited by 523 · cited 2×
“…administration of the selective 5-HT2A receptor antagonist M100907 (Kehne et al, 1996) and the selective 5-HT2C receptor antagonist SB 242084 (Kennett et al, 1997) to provide a direct comparison of these two 5-HT receptor subtypes on ‘cognitive flexibility’ and constituent processes…”
BackgroundInfluentialBerg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510 · cited 1×
“…the highest degree of sequence homology (about 50% overall sequence identity), the apparently different behavioral actions elicited by antagonism at these receptors may be attributable to fundamental differences in signal transduction pathways of the two receptor subtypes (Berg et al, 1994, 1998).”
BackgroundRogers, R. D., Andrews, T. C., Grasby, P. M., Brooks, D. J., & Robbins, T. W. (2000) · Journal of Cognitive Neuroscience · doi:10.1162/089892900561931 · Cited by 458 · cited 1×
“The reversal learning task has been used as a measure of behavioral flexibility in humans (Rolls et al, 1994; Rogers et al, 2000; Murphy et al, 2002; Fellows and Farah, 2003), nonhuman primates (Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; Clarke et al, 2004, 2005, 2007; Lee et al,…”
MethodSelf-citationHarrison, A. A., Everitt, B. J., & Robbins, T. W. (1997) · Psychopharmacology · doi:10.1007/s002130050410 · Cited by 452 · cited 1×
“…drugs such as D-amphetamine which increases DA release in the nucleus accumbens (Cole and Robbins, 1987, 1989): D-amphetamine causes a similar pattern of behavioral effects on the 5CSRTT as SB 242084, increasing the number of premature responses (Cole and Robbins, 1987; Harrison et al, 1997).”
BackgroundSelf-citationFleischhacker, W. W., & Brooks, D. J. (2003) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6020-6 · Cited by 438
Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting
Floresco, S. B., Magyar, O., Ghods-Sharifi, S., Vexelman, C., & Tse, M. T. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300825 · Cited by 395 · cited 1×
“Furthermore, Floresco et al (2006) showed that administration of the D2/D3 subtype selective antagonist eticlopride potently impaired animals’ ability to change their behavior in response to a conditional change of rule in a set-shifting task.”
BackgroundPrefrontal Serotonin Depletion Affects Reversal Learning But Not Attentional Set Shifting
Clarke, H. F., Walker, S. C., Crofts, H. S., Dalley, J. W., Robbins, T. W., & Roberts, A. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3690-04.2005 · Cited by 358 · cited 3×
“…1994; Rogers et al, 2000; Murphy et al, 2002; Fellows and Farah, 2003), nonhuman primates (Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; Clarke et al, 2004, 2005, 2007; Lee et al, 2007), and rats (Birrell and Brown, 2000; McAlonan and Brown, 2003; Idris et al, 2005; van der Meulen et…”
BackgroundSelf-citationKehne, J. H., Baron, B. M., Carr, A. A., Chaney, S. F., Elands, J., Feldman, D. J., Frank, R. A., van Giersbergen, P. L., McCloskey, T. C., Johnson, M. P., et al. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12956-x · Cited by 358 · cited 2×
“…does not influence the spontaneous firing rate of dopaminergic neurons or alter basal levels of DA or norepinephrine (noradrenaline, NA) release (Kehne et al, 1996), but attenuates amphetamine-induced hyperactivity (Sorensen et al, 1993) and amphetamine or DOI or MDMA-induced DA release…”
BackgroundMethodClarke, H., Walker, S., Dalley, J., Robbins, T., & Roberts, A. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj120 · Cited by 351
Self-citationGobert, A., Rivet, J.-M., Lejeune, F., Newman-Tancredi, A., Adhumeau-Auclair, A., Nicolas, J.-P., Cistarelli, L., Melon, C., & Millan, M. J. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000601)36:3<205::aid-syn5>3.0.co;2-d · Cited by 336 · cited 2×
“In contrast, administration of 5-HT2C receptor antagonists, including SB 242084, increases DA and NA release (Millan et al, 1998; Di Matteo et al, 2000a; Gobert et al, 2000) as well as VTA cell firing in the nucleus accumbens (Di Matteo et al, 1999).”
Background5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutic Potential
Martin, J. R., Bös, M., Jenck, F., Moreau, J.-L., Mutel, V., Sleight, A. J., Wichmann, J., Andrews, J. S., Berendsen, H. H. G., Broekkamp, C. L. E., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37669-4 · Cited by 334 · cited 2×
“…receptor activation induced ‘compulsive’ grooming (Graf et al, 2003; Graf, 2006) and directional persistence in spatial alternation (Tsaltas et al, 2005), while in other models 5-HT2C agonists attenuated compulsive behavior (marble burying and schedule-induced polydipsia; Martin et al, 1998a).”
BackgroundWinstanley, C. A., Theobald, D. E. H., Dalley, J. W., Glennon, J. C., & Robbins, T. W. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1884-9 · Cited by 324 · cited 3×
“Systemic injections of drug were given in a volume of 1 ml/ kg. Determination of doses was based on previous studies using the same drugs (Jones et al, 2002; Winstanley et al, 2004).”
BackgroundMethodSelf-citationCole, B. J., & Robbins, T. W. (1989) · Behavioural Brain Research · doi:10.1016/s0166-4328(89)80048-8 · Cited by 314 · cited 1×
“…been shown to mimic some of the effects of psychostimulant drugs such as D-amphetamine which increases DA release in the nucleus accumbens (Cole and Robbins, 1987, 1989): D-amphetamine causes a similar pattern of behavioral effects on the 5CSRTT as SB 242084, increasing the number of…”
BackgroundSelf-citationTryptophan depletion in normal volunteers produces selective impairments in learning and memory
Park, S. B., Coull, J. T., McShane, R. H., Young, A. H., Sahakian, B. J., Robbins, T. W., & Cowen, P. J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90089-2 · Cited by 310 · cited 1×
“This finding is reminiscent of the effects of dietary tryptophan depletion in humans (Park et al, 1994) or selective (5,7-DHT) destruction of the ascending serotonergic projections in animals (Clarke et al, 2004, 2005, 2007).”
BackgroundSelf-citationBoulougouris, V., Dalley, J. W., & Robbins, T. W. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.02.005 · Cited by 297 · cited 14×
“It is noteworthy that OFC lesions (marmoset, Dias et al, 1996; rat, Boulougouris et al, 2007) also impaired the first reversal only.”
BackgroundMethodInfluentialSelf-citationMillan, M. J., Dekeyne, A., & Gobert, A. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00078-1 · Cited by 283 · cited 3×
“For example, 5-HT2C receptors appear to inhibit DA release, whereas activation of 5-HT2A receptors enhances it (Millan et al, 1998; Di Matteo et al, 2001, 2002).”
BackgroundBussey, T. J., Muir, J. L., Everitt, B. J., & Robbins, T. W. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.5.920 · Cited by 259 · cited 1×
“Type of errors were further analyzed as described previously (Boulougouris et al, 2007) according to the method of Dias et al (1996) and Bussey et al (1997), modified from Jones and Mishkin (1972).”
MethodSelf-citationSorensen, S. M., Kehne, J. H., Fadayel, G. M., Humphreys, T. M., Ketteler, H. J., Sullivan, C. K., Taylor, V. L., & Schmidt, C. J. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38366-7 · Cited by 258 · cited 1×
“…neurons or alter basal levels of DA or norepinephrine (noradrenaline, NA) release (Kehne et al, 1996), but attenuates amphetamine-induced hyperactivity (Sorensen et al, 1993) and amphetamine or DOI or MDMA-induced DA release (Schmidt et al, 1994; Gobert and Millan, 1999; Porras et al, 2002).”
BackgroundThe effects of tryptophan depletion on cognitive and affective processing in healthy volunteers
Murphy, F., Smith, K., Cowen, P., Robbins, T., & Sahakian, B. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1128-9 · Cited by 255 · cited 1×
“The reversal learning task has been used as a measure of behavioral flexibility in humans (Rolls et al, 1994; Rogers et al, 2000; Murphy et al, 2002; Fellows and Farah, 2003), nonhuman primates (Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; Clarke et al, 2004, 2005, 2007; Lee et al,…”
MethodSelf-citationBarker, E. L., Westphal, R. S., Schmidt, D., & Sanders-Bush, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32625-x · Cited by 254
Fletcher, P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00342-1 · Cited by 251
Di Matteo, V., Di Giovanni, G., Di Mascio, M., & Esposito, E. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00047-7 · Cited by 251 · cited 2×
“In contrast, administration of 5-HT2C receptor antagonists, including SB 242084, increases DA and NA release (Millan et al, 1998; Di Matteo et al, 2000a; Gobert et al, 2000) as well as VTA cell firing in the nucleus accumbens (Di Matteo et al, 1999).”
BackgroundPattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats
Eberle-Wang, K., Mikeladze, Z. A., Uryu, K., & Chesselet, M. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970728)384:2<233::aid-cne5>3.0.co;2-2 · Cited by 251 · cited 1×
“Eberle-Wang et al (1997) demonstrated the presence of 5-HT2C mRNA within inhibitory GABAergic interneurons making direct synaptic contact with dopaminergic cell bodies in both the VTA and substantia nigra.”
BackgroundAbramowski, D., Rigo, M., Duc, D., Hoyer, D., & Staufenbiel, M. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00138-7 · Cited by 243 · cited 1×
“…including the neocortex, amygdala, hippocampus, dorsal, and ventral (including nucleus accumbens) striatal regions, as well as in monoaminergic cell body-rich areas such as the locus coeruleus, substantia nigra, and VTA (Pompeiano et al, 1994; Abramowski et al, 1995; EberleWang et al, 1997).”
BackgroundCole, B. J., & Robbins, T. W. (1987) · Psychopharmacology · doi:10.1007/bf00216011 · Cited by 240 · cited 3×
“…been shown to mimic some of the effects of psychostimulant drugs such as D-amphetamine which increases DA release in the nucleus accumbens (Cole and Robbins, 1987, 1989): D-amphetamine causes a similar pattern of behavioral effects on the 5CSRTT as SB 242084, increasing the number of…”
BackgroundSelf-citationVeale, D. M., Sahakian, B. J., Owen, A. M., & Marks, I. M. (1996) · Psychological Medicine · doi:10.1017/s0033291700035984 · Cited by 239 · cited 1×
“They also show impairments on laboratory tests of frontal lobe function involving response shifting and inhibitory processing that correlate with the severity of their symptoms (Veale et al, 1996; Rosenberg et al, 1997; Schmidtke et al, 1998; Hollander and Rosen, 2000).”
BackgroundWinstanley, C. A., Chudasama, Y., Dalley, J. W., Theobald, D. E. H., Glennon, J. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1398-x · Cited by 234 · cited 1×
“Specifically, studies utilizing the 5CSRTT have shown that M100907 decreases premature but not perseverative responses (Winstanley et al, 2003).”
BackgroundSelf-citationRole of 5-HT2C receptors in the control of central dopamine function
Di Matteo, V., De Blasi, A., Di Giulio, C., & Esposito, E. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01688-6 · Cited by 234 · cited 1×
“For example, 5-HT2C receptors appear to inhibit DA release, whereas activation of 5-HT2A receptors enhances it (Millan et al, 1998; Di Matteo et al, 2001, 2002).”
Background5-HT2A and 5-HT2C receptors and their atypical regulation properties
Van Oekelen, D., Luyten, W. H. M. L., & Leysen, J. E. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00141-3 · Cited by 224 · cited 1×
“This latter hypothesis has been strengthened from reports on 5-HT2C downregulation following chronic treatment with SSRIs (van Oekelen et al, 2003; Serretti et al, 2004).”
BackgroundPorras, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00333-5 · Cited by 222 · cited 1×
“…neurons or alter basal levels of DA or norepinephrine (noradrenaline, NA) release (Kehne et al, 1996), but attenuates amphetamine-induced hyperactivity (Sorensen et al, 1993) and amphetamine or DOI or MDMA-induced DA release (Schmidt et al, 1994; Gobert and Millan, 1999; Porras et al, 2002).”
BackgroundSelective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907
López-Giménez, J. F., Mengod, G., Palacios, J. M., & Vilaró, M. T. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005075 · Cited by 205 · cited 1×
“The 5-HT2A receptors are particularly prominent in cortical areas but are also found in DA-rich areas such as the striatum, substantia nigra, and VTA (Pompeiano et al, 1994; Lopez-Gimenez et al, 1997; Doherty and Pickel, 2000).”
BackgroundThe effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates
Barnes, J. M., Costall, B., Coughlan, J., Domeney, A. M., Gerrard, P. A., Kelly, M. E., Naylor, R. J., Onaivi, E. S., Tomkins, D. M., & Tyers, M. B. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90385-u · Cited by 195 · cited 1×
“Deficits were found in 5-HT-deficient rats following a tryptophan-deficient diet and monkeys with high doses of the 5-HT3 antagonist ondansetron (Barnes et al, 1990; Domeney et al, 1991).”
BackgroundInfluentialCarli, M., Baviera, M., Invernizzi, R. W., & Balducci, C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300893 · Cited by 187 · cited 1×
“In another study (Carli et al, 2006), infusions of M100907 in the medial prefrontal cortex (mPFC) counteracted the loss of executive control (impulsivity increase induced by the competitive NMDA receptor antagonist 3-(R)-2-carboxypiperazin-4-propyl-1-propyl-1-phosphonic acid), while the selective…”
BackgroundDi Matteo, V., Di Giovanni, G., Di Mascio, M., & Esposito, E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02246-0 · Cited by 184 · cited 2×
“In contrast, administration of 5-HT2C receptor antagonists, including SB 242084, increases DA and NA release (Millan et al, 1998; Di Matteo et al, 2000a; Gobert et al, 2000) as well as VTA cell firing in the nucleus accumbens (Di Matteo et al, 1999).”
BackgroundHiggins, G. A., Enderlin, M., Haman, M., & Fletcher, P. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1549-0 · Cited by 179 · cited 1×
“…response control, recent reports indicate that the 5-HT2C receptor antagonist SB 242084 increases premature responding on the five-choice serial reaction time task (5CSRTT), whereas 5-HT2A receptor antagonist M100907 decreases the same measure (Higgins et al, 2003; Winstanley et al, 2004).”
BackgroundBasolateral Amygdala Lesions Abolish Orbitofrontal-Dependent Reversal Impairments
Stalnaker, T. A., Franz, T. M., Singh, T., & Schoenbaum, G. (2007) · Neuron · doi:10.1016/j.neuron.2007.02.014 · Cited by 178 · cited 1×
“…and Brown, 2003; Boulougouris et al, 2007) and the ventrolateral sector of caudate nucleus (monkey, Divac et al, 1967; rat, Dunnett and Iversen, 1980), while a recent study demonstrated that basolateral amygdala lesions abolished OFC-induced reversal learning impairments (Stalnaker et al, 2007).”
BackgroundDoherty, M. D., & Pickel, V. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02062-x · Cited by 177 · cited 5×
“Eberle-Wang et al (1997) demonstrated the presence of 5-HT2C mRNA within inhibitory GABAergic interneurons making direct synaptic contact with dopaminergic cell bodies in both the VTA and substantia nigra.”
BackgroundInfluentialCognitive Frontal Lobe Dysfunction in Obsessive-Compulsive Disorder
Schmidtke, K., Schorb, A., Winkelmann, G., & Hohagen, F. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00355-7 · Cited by 172 · cited 1×
“They also show impairments on laboratory tests of frontal lobe function involving response shifting and inhibitory processing that correlate with the severity of their symptoms (Veale et al, 1996; Rosenberg et al, 1997; Schmidtke et al, 1998; Hollander and Rosen, 2000).”
BackgroundGobert, A., & Millan, M. J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00188-9 · Cited by 171 · cited 2×
“M100907 does not influence the spontaneous firing rate of dopaminergic neurons or alter basal levels of DA or norepinephrine (noradrenaline, NA) release (Kehne et al, 1996), but attenuates amphetamine-induced hyperactivity (Sorensen et al, 1993) and amphetamine or DOI or MDMA-induced DA release (Schmidt et al, 1994; G…”
BackgroundOrbitofrontal function, object alternation and perseveration
Freedman, M. (1998) · Cerebral Cortex · doi:10.1093/cercor/8.1.18 · Cited by 165 · cited 1×
“Although OCD patients are not markedly impaired on simple reversal learning, they have impairments in other tasks sensitive to OFC function such as alternation learning, a task related to reversal learning (Freedman et al, 1998).”
BackgroundRole of serotonin2C receptors in the control of brain dopaminergic function
Matteo, V. D., Cacchio, M., Giulio, C. D., & Esposito, E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00705-5 · Cited by 164 · cited 1×
“For example, 5-HT2C receptors appear to inhibit DA release, whereas activation of 5-HT2A receptors enhances it (Millan et al, 1998; Di Matteo et al, 2001, 2002).”
BackgroundSerotonin and drug reward: focus on 5-HT2C receptors
Higgins, G. A., & Fletcher, P. J. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.102 · Cited by 160 · cited 2×
“Accumulating evidence attributes the proaddictive effects of 5-HT2C antagonists to increase of burst firing of dopaminergic neurons in the ventral tegmental area (VTA), leading to increased release of DA in the nucleus accumbens (Millan et al, 1998; Di Matteo et al, 1999, 2000a, b, 2001, 2002; Gobert et al, 2000; Di G…”
BackgroundHollander, E., & Rosen, J. (2000) · Journal of Psychopharmacology · doi:10.1177/02698811000142s106 · Cited by 155
Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety
Martin, J. R., Ballard, T. M., & Higgins, G. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00713-4 · Cited by 151 · cited 1×
“On the other hand, blockade of 5-HT2C receptors increased compulsive drinking in the polydipsia model (Martin et al, 2002), whereas E Tsaltas et al (unpublished observations) have shown that SB 242084 protected against metachlorophenylpiperazine (mCPP; a nonselective serotonin agonist)-induced…”
BackgroundEvenden, J. L., & Robbins, T. W. (1983) · Psychopharmacology · doi:10.1007/bf00427498 · Cited by 151 · cited 1×
“However, other studies have reported D-amphetamine facilitation of reversal learning in a two-choice simultaneous brightness discrimination (Weiner et al, 1986; Weiner and Feldon, 1986) and enhanced switching behavior (Evenden and Robbins, 1983; van den Bos and Cools, 1989).”
BackgroundSelf-citationLee, B., Groman, S., London, E. D., & Jentsch, J. D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301337 · Cited by 148 · cited 2×
“Ridley et al (1981) demonstrated impaired reversal after the D2 receptor antagonist haloperidol, while Lee et al (2007) showed that the selective D2/D3 receptor antagonist, raclopride, impairs reversal learning in monkeys.”
BackgroundLiégeois, J.-F., Ichikawa, J., & Meltzer, H. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02620-3 · Cited by 145 · cited 1×
“Selective blockade of 5-HT2A receptors, for example, enhances the effect of D2 receptor blockade on ventral midbrain DA cell firing (Olijslagers et al, 2004, 2005) and on limbic DA release (Bonaccorso et al, 2002; Liegeois et al, 2002).”
Mechanisms of action of current and potential pharmacotherapies of obsessive–compulsive disorder
El Mansari, M., & Blier, P. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.005 · Cited by 142 · cited 1×
“The serotonergic system is also implicated in OCD, for example, via the therapeutic effects of specific serotonin reuptake inhibitors (SSRIs) (Baumgarten and Grozdanovic, 1998; El Mansari and Blier, 2006).”
BackgroundMeta-analysis of pharmacotherapy trials for obsessive-compulsive disorder
Stein, D. J., Spadaccini, E., & Hollander, E. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199503000-00002 · Cited by 138 · cited 1×
“Given that addiction and compulsivity seem to share underlying neural substrates such as the OFC and the DA system (Stein et al, 1995; Jentsch and Taylor, 1999; Everitt and Robbins, 2005; Kalivas and Volkow, 2005), the present finding that SB 242084 reduced perseverative responding suggests that…”
BackgroundRosenberg, D. R., Dick, E. L., O’Hearn, K. M., & Sweeney, J. A. (1997) · PubMed Central · Cited by 134
Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
Berg, K. A., Clarke, W. P., Sailstad, C., Saltzman, A., & Maayani, S. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09724-x · Cited by 134 · cited 1×
“…the highest degree of sequence homology (about 50% overall sequence identity), the apparently different behavioral actions elicited by antagonism at these receptors may be attributable to fundamental differences in signal transduction pathways of the two receptor subtypes (Berg et al, 1994, 1998).”
BackgroundSchmidt, C. J., Sullivan, C. K., & Fedayal, G. M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62041382.x · Cited by 131 · cited 1×
“…neurons or alter basal levels of DA or norepinephrine (noradrenaline, NA) release (Kehne et al, 1996), but attenuates amphetamine-induced hyperactivity (Sorensen et al, 1993) and amphetamine or DOI or MDMA-induced DA release (Schmidt et al, 1994; Gobert and Millan, 1999; Porras et al, 2002).”
BackgroundIdris, N. F., Repeto, P., Neill, J. C., & Large, C. H. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2058-5 · Cited by 131 · cited 2×
“Moreover, it has been shown to impair reversal-test performance (Ridley et al, 1998; Bensadoun et al, 2004; Idris et al, 2005).”
BackgroundGiovanni, G. D., Matteo, V. D., Grutta, V. L., & Esposito, E. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00561-3 · Cited by 125 · cited 1×
“…to increase of burst firing of dopaminergic neurons in the ventral tegmental area (VTA), leading to increased release of DA in the nucleus accumbens (Millan et al, 1998; Di Matteo et al, 1999, 2000a, b, 2001, 2002; Gobert et al, 2000; Di Giovanni et al, 2001; Higgins and Fletcher, 2003).”
BackgroundSystemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats
Martin, P., Carlsson, M. L., & Hjorth, S. (1998) · NeuroReport · doi:10.1097/00001756-199809140-00012 · Cited by 118 · cited 2×
“…receptor activation induced ‘compulsive’ grooming (Graf et al, 2003; Graf, 2006) and directional persistence in spatial alternation (Tsaltas et al, 2005), while in other models 5-HT2C agonists attenuated compulsive behavior (marble burying and schedule-induced polydipsia; Martin et al, 1998a).”
BackgroundRole of serotonin in obsessive-compulsive disorder
Baumgarten, H. G., & Grozdanovic, Z. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297857 · Cited by 114 · cited 1×
“The serotonergic system is also implicated in OCD, for example, via the therapeutic effects of specific serotonin reuptake inhibitors (SSRIs) (Baumgarten and Grozdanovic, 1998; El Mansari and Blier, 2006).”
BackgroundKennett, G. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90133-3 · Cited by 110 · cited 1×
“…which assessed the behavioral response to mCPP following chronic treatment with SSRIs have shown attenuated response to mCPP suggesting that chronic treatment with SSRIs leads to desensitization of 5- HT2C receptors (Kennedy et al, 1993; Kennett et al, 1994; Maj et al, 1996; Yamauchi et al, 2004).”
BackgroundKhullar, A., Chue, P. S., & Tibbo, P. G. (2001) · PubMed Central · Cited by 107
Fletcher, P. J., Korth, K. M., Robinson, S. K., & Baker, G. B. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1104-4 · Cited by 95
The involvement of the nucleus accumbens in the ability of rats to switch to cue-directed behaviours
van den Bos, R., & Cools, A. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90486-4 · Cited by 88 · cited 1×
“However, other studies have reported D-amphetamine facilitation of reversal learning in a two-choice simultaneous brightness discrimination (Weiner et al, 1986; Weiner and Feldon, 1986) and enhanced switching behavior (Evenden and Robbins, 1983; van den Bos and Cools, 1989).”
BackgroundHallucinogen-induced relief of obsessions and compulsions
Moreno, F., & Delgado, P. L. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.7.1037b · Cited by 85 · cited 2×
“Treatment with psychedelic drugs possessing potent 5-HT2A/2C agonist action properties appears to have favorable results on OCD patients (Moreno and Delgado, 1997; Delgado and Moreno 1998a, b; Delgado, 2000), and 5- HT2C receptor antagonism has been suggested to play a role in the generation of…”
BackgroundThe effect of ondansetron on cognitive performance in the marmoset
Domeney, A. M., Costall, B., Gerrard, P. A., Jones, D. N. C., Naylor, R. J., & Tyers, M. B. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90606-3 · Cited by 84 · cited 2×
“Deficits were found in 5-HT-deficient rats following a tryptophan-deficient diet and monkeys with high doses of the 5-HT3 antagonist ondansetron (Barnes et al, 1990; Domeney et al, 1991).”
BackgroundInfluentialThe effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain
Maj, J., Bijak, M., Dziedzicka‐Wasylewska, M., Rogoż, R., Rogóż, Z., Skuza, G., & Tokarski, T. (1996) · Psychopharmacology · doi:10.1007/bf02805977 · Cited by 81 · cited 1×
“…which assessed the behavioral response to mCPP following chronic treatment with SSRIs have shown attenuated response to mCPP suggesting that chronic treatment with SSRIs leads to desensitization of 5- HT2C receptors (Kennedy et al, 1993; Kennett et al, 1994; Maj et al, 1996; Yamauchi et al, 2004).”
BackgroundBonaccorso, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00311-1 · Cited by 80 · cited 1×
“Selective blockade of 5-HT2A receptors, for example, enhances the effect of D2 receptor blockade on ventral midbrain DA cell firing (Olijslagers et al, 2004, 2005) and on limbic DA release (Bonaccorso et al, 2002; Liegeois et al, 2002).”
BackgroundAn analysis of visual object reversal learning in the marmoset after amphetamine and haloperidol
Ridley, R. M., Haystead, T., & Baker, H. F. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90401-9 · Cited by 80 · cited 1×
“Ridley et al (1981) demonstrated impaired reversal after the D2 receptor antagonist haloperidol, while Lee et al (2007) showed that the selective D2/D3 receptor antagonist, raclopride, impairs reversal learning in monkeys.”
BackgroundDo antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms?
Sareen, J., Kirshner, A., Lander, M., Kjernisted, K. D., Eleff, M. K., & Reiss, J. P. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.03.011 · Cited by 79 · cited 1×
“…HT2C receptor antagonism has been suggested to play a role in the generation of obsessive-compulsive symptoms in patients with comorbid psychiatric disorder, although this effect was not reported in patients suffering from primary/ pure OCD (Khullar et al, 2001; see Sareen et al, 2004 for review).”
ResultDopamine D2receptors mediate two-odor discrimination and reversal learning in C57BL/6 mice
Kruzich, P. J., & Grandy, D. K. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-12 · Cited by 79 · cited 1×
“Finally, selective blockade of D2 receptor gene in knockout mice impaired reversal learning of an odor discrimination (Kruzich and Grandy, 2004).”
BackgroundCeglia, I., Carli, M., Baviera, M., Renoldi, G., Calcagno, E., & Invernizzi, R. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02704.x · Cited by 79 · cited 1×
“In contrast, M100907 has been shown to exert its behavioral effects (reduced hyperactivity after NMDA receptor antagonism) under conditions of increased 5-HT release, while low-5-HT tone abolishes these effects (Martin et al, 1998b; Ceglia et al, 2004).”
BackgroundTsaltas, E., Kontis, D., Chrysikakou, S., Giannou, H., Biba, A., Pallidi, S., Christodoulou, A., Maillis, A., & Rabavilas, A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.020 · Cited by 78 · cited 1×
“5-HT2C receptor activation induced ‘compulsive’ grooming (Graf et al, 2003; Graf, 2006) and directional persistence in spatial alternation (Tsaltas et al, 2005), while in other models 5-HT2C agonists attenuated compulsive behavior (marble burying and schedule-induced polydipsia; Martin et al,…”
BackgroundHutson, P. H., Barton, C. L., Jay, M. T., Blurton, P., Burkamp, F., Clarkson, R., & Bristow, L. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00089-7 · Cited by 76 · cited 1×
“Effects of 5-HT2C receptor antagonism have also been reported to enhance the stimulant effects (eg suppression of motivated behavior, locomotor activity, etc) of several drugs of abuse (phencyclidine, 3,4-methylenedioxymethamphetamine (MDMA); Hutson et al, 2000; Fletcher et al, 2001, 2002a, b).”
Backgroundvan der Meulen, J. A. J., Joosten, R. N. J. M. A., de Bruin, J. P. C., & Feenstra, M. G. P. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl057 · Cited by 75 · cited 1×
“…et al, 2002; Fellows and Farah, 2003), nonhuman primates (Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; Clarke et al, 2004, 2005, 2007; Lee et al, 2007), and rats (Birrell and Brown, 2000; McAlonan and Brown, 2003; Idris et al, 2005; van der Meulen et al, 2006; Boulougouris et al, 2007).”
Hallucinogens, Serotonin and Obsessive-Compulsive Disorder
Delgado, P. L., & Moreno, F. A. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399711 · Cited by 64 · cited 1×
“…psychedelic drugs possessing potent 5-HT2A/2C agonist action properties appears to have favorable results on OCD patients (Moreno and Delgado, 1997; Delgado and Moreno 1998a, b; Delgado, 2000), and 5- HT2C receptor antagonism has been suggested to play a role in the generation of…”
BackgroundReversal and nonreversal shifts under amphetamine
Weiner, I., & Feldon, J. (1986) · Psychopharmacology · doi:10.1007/bf00174374 · Cited by 63 · cited 1×
“However, other studies have reported D-amphetamine facilitation of reversal learning in a two-choice simultaneous brightness discrimination (Weiner et al, 1986; Weiner and Feldon, 1986) and enhanced switching behavior (Evenden and Robbins, 1983; van den Bos and Cools, 1989).”
Backgroundm-CPP-induced self-grooming is mediated by 5-HT2C receptors
Gráf, M., Kántor, S., Anheuer, Z. E., Modos, E. A., & Bagdy, G. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00404-7 · Cited by 63 · cited 1×
“5-HT2C receptor activation induced ‘compulsive’ grooming (Graf et al, 2003; Graf, 2006) and directional persistence in spatial alternation (Tsaltas et al, 2005), while in other models 5-HT2C agonists attenuated compulsive behavior (marble burying and schedule-induced polydipsia; Martin et al,…”
BackgroundSettlage, P. H., Zable, M., & Harlow, H. F. (1948) · Journal of Experimental Psychology · doi:10.1037/h0054430 · Cited by 60 · cited 1×
“Converging evidence from a number of studies has implicated the orbitofrontal cortex (OFC) (human, Rolls et al, 1994; nonhuman primate, Settlage et al, 1948; Jones and Mishkin, 1972; Butter, 1969; Dias et al, 1996; rat, Chudasama and Robbins, 2003; McAlonan and Brown, 2003; Boulougouris et al,…”
BackgroundThe 5-HT2C receptor as a target for mood disorders
Serretti, A., Artioli, P., & De Ronchi, D. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.1.15 · Cited by 60 · cited 1×
“This latter hypothesis has been strengthened from reports on 5-HT2C downregulation following chronic treatment with SSRIs (van Oekelen et al, 2003; Serretti et al, 2004).”
BackgroundButter, C. M. (1969) · Brain Research · doi:10.1016/0006-8993(69)90006-7 · Cited by 58 · cited 12×
“It is noteworthy that OFC lesions (marmoset, Dias et al, 1996; rat, Boulougouris et al, 2007) also impaired the first reversal only.”
BackgroundMethodInfluentialRegulatory impairments following selective kainic acid lesions of the neostriatum
Dunnett, S. B., & Iversen, S. D. (1980) · Behavioural Brain Research · doi:10.1016/0166-4328(80)90004-2 · Cited by 58 · cited 1×
“…Robbins, 2003; McAlonan and Brown, 2003; Boulougouris et al, 2007) and the ventrolateral sector of caudate nucleus (monkey, Divac et al, 1967; rat, Dunnett and Iversen, 1980), while a recent study demonstrated that basolateral amygdala lesions abolished OFC-induced reversal learning impairments…”
BackgroundChronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats
Yamauchi, M., Tatebayashi, T., Nagase, K., Kojima, M., & Imanishi, T. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.05.003 · Cited by 58 · cited 1×
“…which assessed the behavioral response to mCPP following chronic treatment with SSRIs have shown attenuated response to mCPP suggesting that chronic treatment with SSRIs leads to desensitization of 5- HT2C receptors (Kennedy et al, 1993; Kennett et al, 1994; Maj et al, 1996; Yamauchi et al, 2004).”
BackgroundEffects of RO 60 0175, a 5-HT2C receptor agonist, in three animal models of anxiety
Kennett, G. A., Lightowler, S., Trail, B. K., Bright, F., & Bromidge, S. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00706-2 · Cited by 56 · cited 1×
“It should be noted that the anticompulsive effects of 5-HT2C agonists have been attributed to their sedative effects (Kennett et al, 2000).”
BackgroundWeiner, I., Feldon, J., & Ben‐Shahar, O. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90066-3 · Cited by 54 · cited 1×
“However, other studies have reported D-amphetamine facilitation of reversal learning in a two-choice simultaneous brightness discrimination (Weiner et al, 1986; Weiner and Feldon, 1986) and enhanced switching behavior (Evenden and Robbins, 1983; van den Bos and Cools, 1989).”
BackgroundKennedy, A. J., Gibson, E. L., O’Connell, M. T., & Curzon, G. (1993) · Psychopharmacology · doi:10.1007/bf02245708 · Cited by 50 · cited 1×
“…which assessed the behavioral response to mCPP following chronic treatment with SSRIs have shown attenuated response to mCPP suggesting that chronic treatment with SSRIs leads to desensitization of 5- HT2C receptors (Kennedy et al, 1993; Kennett et al, 1994; Maj et al, 1996; Yamauchi et al, 2004).”
BackgroundEastwood, S. L., Burnet, P. W. J., & Harrison, P. J. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000601)36:3<167::aid-syn2>3.0.co;2-d · Cited by 48
Serotonin Neurotransmission in Cocaine Sensitizationa
Cunningham, K. A., Paris, J. M., & Goeders, N. E. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25960.x · Cited by 47 · cited 1×
“Moreover, antagonism of 5-HT2C receptors potentiates some of the behavioral effects of cocaine, whereas antagonism of 5-HT2A receptors attenuates both cocaine-induced hypermotility and reinstatement of cocaine-seeking (Cunningham et al, 1992; Fletcher et al, 2002).”
BackgroundSB 242084: A Selective 5‐HT2CReceptor Antagonist
Matteo, V. D., Giovanni, G. D., & Esposito, E. (2000) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2000.tb00147.x · Cited by 45 · cited 2×
“In contrast, administration of 5-HT2C receptor antagonists, including SB 242084, increases DA and NA release (Millan et al, 1998; Di Matteo et al, 2000a; Gobert et al, 2000) as well as VTA cell firing in the nucleus accumbens (Di Matteo et al, 1999).”
BackgroundBensadoun, J., Brooks, S. P., & Dunnett, S. B. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1751-0 · Cited by 38 · cited 1×
“Moreover, it has been shown to impair reversal-test performance (Ridley et al, 1998; Bensadoun et al, 2004; Idris et al, 2005).”
BackgroundOlijslagers, J. E., Werkman, T. R., McCreary, A. C., Siarey, R. J., Kruse, C. G., & Wadman, W. J. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.003 · Cited by 38 · cited 1×
“Selective blockade of 5-HT2A receptors, for example, enhances the effect of D2 receptor blockade on ventral midbrain DA cell firing (Olijslagers et al, 2004, 2005) and on limbic DA release (Bonaccorso et al, 2002; Liegeois et al, 2002).”
BackgroundKING, A. R., MARTIN, I. L., & MELVILLE, K. A. (1974) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1974.tb08611.x · Cited by 37 · cited 1×
“However, low doses of ondansetron (Domeney et al, 1991) and lysergic acid diethylamide (LSD) improved reversal learning (King et al, 1974), although these effects were not specific to reversal learning per se.”
BackgroundDelgado, P. L., & Moreno, F. A. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297869 · Cited by 31 · cited 1×
“…psychedelic drugs possessing potent 5-HT2A/2C agonist action properties appears to have favorable results on OCD patients (Moreno and Delgado, 1997; Delgado and Moreno 1998a, b; Delgado, 2000), and 5- HT2C receptor antagonism has been suggested to play a role in the generation of…”
BackgroundRidley, R. M., Baker, H. F., Frith, C., Dowdy, J., & Crow, T. (1988) · Psychopharmacology · doi:10.1007/bf00172977 · Cited by 29 · cited 1×
“Moreover, it has been shown to impair reversal-test performance (Ridley et al, 1998; Bensadoun et al, 2004; Idris et al, 2005).”
BackgroundGráf, M. (2006) · PubMed · Cited by 29
Jones, N., Duxon, M. S., & King, S. M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1197-9 · Cited by 28 · cited 1×
“Systemic injections of drug were given in a volume of 1 ml/ kg. Determination of doses was based on previous studies using the same drugs (Jones et al, 2002; Winstanley et al, 2004).”
Method5HT‐2 receptor and fluvoxamine effect in obsessive‐compulsive disorder
Erzegovesi, S., Ronchi, P., & Smeraldi, E. (1992) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470070409 · Cited by 27 · cited 1×
“Furthermore, the 5-HT2 antagonist ritanserin reversed the therapeutic effect of fluvoxamine (Erzegovesi et al, 1992), while studies which assessed the behavioral response to mCPP following chronic treatment with SSRIs have shown attenuated response to mCPP suggesting that chronic treatment with…”
BackgroundOlijslagers, J. E., Perlstein, B., Werkman, T. R., McCreary, A. C., Siarey, R. J., Kruse, C. G., & Wadman, W. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.014 · Cited by 10 · cited 1×
“Selective blockade of 5-HT2A receptors, for example, enhances the effect of D2 receptor blockade on ventral midbrain DA cell firing (Olijslagers et al, 2004, 2005) and on limbic DA release (Bonaccorso et al, 2002; Liegeois et al, 2002).”
BackgroundPharmacological Treatment of Obsessive‐Compulsive Disorder: A Review
Zohar, J., Sasson, Y., Chopra, M., Amital, D., & Iancu, I. (2002) · doi:10.1002/0470861657.ch2 · Cited by 7
Research works printed but not linked: 3
- Fletcher PJ, Grottick AJ, Higgins GA (2001). Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Soc Neurosci Abs 27: 441.15.
- Fletcher PJ, Korth KM, Robinson SR, Baker GB (2002b). Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology (Berl) 162: 282–291. · DOI
- Soubrié P (1986). Serotonergic neurons and behaviour. J Pharmacol 17: 107–112.
Cited by
Stress signalling pathways that impair prefrontal cortex structure and function
Arnsten, A. F. T. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2648 · Cited by 3,299
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
“There is a growing body of evidence that enhanced 5-HT2AR signalling produces a plastic state (in the sense of an enhanced capacity for change), both psychologically (Boulougouris et al., 2008; Carhart-Harris et al., 2015a, 2016c; Clarke et al., 2007; Kaelen et al., 2015; Kuypers et al., 2016) and neurobiologically (A…”
BackgroundInfluentialThe neural basis of reversal learning: An updated perspective
Izquierdo, A., Brigman, J. L., Radke, A. K., Rudebeck, P. H., & Holmes, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.021 · Cited by 670
“For instance, in rats antagonism of 5-HT2A (via MDL 100-907) impairs reversal performance, while 5-HT2C antagonism (with SB 242084) facilitates performance (Boulougouris et al., 2008; Boulougouris and Robbins, 2010; Nilsson et al., 2012; Furr et al., 2012b), though there is also a report of an overall impairment after…”
Background
Metadata
- Authors
- Boulougouris, V., Glennon, J. C., & Robbins, T. W.
- Affiliations
- University of Cambridge (GB)
- National University of Ireland, Maynooth (IE)
- Corresponding author
- Boulougouris, Vasileios
- Venue
- Neuropsychopharmacology
- Published
- 2007-10-24
- Volume
- 33
- Issue
- 8
- Pages
- 2007-2019
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1971459727
- Cited by
- 219
- References
- 112
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 12 · 2023: 5 · 2022: 11 · 2021: 14 · 2020: 16 · 2019: 9 · 2018: 13 · 2017: 14 · 2016: 13 · 2015: 25 · 2014: 11 · 2013: 15 · 2012: 6
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- 5-HT2A receptor, 5-HT2C receptor, serotonin receptors, reversal learning, cognitive flexibility, response inhibition, perseverative responding, spatial discrimination, M100907, SB242084, obsessive-compulsive disorder, cognitive impairment
- MeSH terms
- Aminopyridines, Animals, Cognition, Conditioning, Operant, Discrimination Learning, Fluorobenzenes, Indoles, Male, Piperidines, Psychomotor Performance, Reinforcement Schedule, Reversal Learning, Serotonin Antagonists, Space Perception, Receptor, Serotonin, 5-HT2A, Receptor, Serotonin, 5-HT2C, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.